oxyphenbutazone hydrate
A hydrate obtained by combining oxyphenbutazone with one molar equivalent of water. Commonly used to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
Chemical structure
| Molecular formula | C19H20N2O3.H2O |
|---|---|
| Charge | 0 |
| Average mass | 342.395 Da |
| Monoisotopic mass | 342.15796 Da |
| Source | ChEBI |
| InChIKey | CNDQSXOVEQXJOE-UHFFFAOYSA-N |
CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O.O
InChI=1S/C19H20N2O3.H2O/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15;/h4-8,10-13,17,22H,2-3,9H2,1H3;1H2
Also called
- Tandearil
- 4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione—water (1/1)
- 4-Butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione monohydrate
- 4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione hydrate
- Oxyphenbutazone
- oxyphenbutazone monohydrate
Cross-references
- cas:7081-38-1
- reaxys:5786228
Drug registries
Patents and articles
Activity roles
- antimicrobial agent
CHEBI:33281
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| CHEBI | CHEBI:76259 |
oxyphenbutazone hydrate | antibioticmech:chebi-051628687d |
2026-08-30 |
Mechanism summary
- Clinical status
- APPROVED
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories